A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Sven van der Lee, Olivia J. Conway, Iris Hansen, Minerva M. Carrasquillo, Luca Kleineidam, Erik van den Akker, Marc Hulsman, Niccolo Tesi, Marcel J.T. Reinders, More Authors

Research output: Contribution to journalArticleScientificpeer-review

39 Citations (Scopus)
51 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity'. Together they form a unique fingerprint.

Medicine & Life Sciences